Viewing Study NCT00833768


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2026-01-26 @ 11:33 PM
Study NCT ID: NCT00833768
Status: TERMINATED
Last Update Posted: 2015-03-24
First Post: 2009-01-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis
Sponsor: Genzyme, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SVCARB00606
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators